Drug recall · May 31, 2017
SATO CLEAR recall
Why: Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-044-01
- Lots / codes
Lot #: WXWZ, Exp. March 2019; WXTS, Exp. October 2019
- Quantity
- 4,790 bottles
- Company
- Sato Pharmaceutical Inc., Torrance, CA
- Distribution
- US: Hawaii, Guam, Saipan, SPI
- Initiated
- February 16, 2017 · Voluntary: Firm initiated
- Classified
- May 23, 2017
- Reported
- May 31, 2017
- Ended
- March 13, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Naphazoline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.